Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

July 25, 2017

At a time when life-saving antiretrovirals are more widely available than ever, an unacceptably high number of people are still dying of AIDS in sub-Saharan Africa.

July 25, 2017

Greater global attention is needed to prevent and treat AIDS, as too many patients are dying despite the availability of antiretroviral treatment.

June 27, 2017

November 10, 2016

Today is World Pneumonia Day. It's a somewhat abstract concept, associating a specific disease with a specific day, but the reality of pneumonia is very scary and dangerous, and possibly even deadly, for millions and millions of people around the globe.

Each year, pneumonia takes the lives of nearly one million children worldwide, often for want of a vaccine. There is in fact a vaccine to prevent it, something that's commonly administered to children in many western countries, but it’s too expensive for many countries to afford.

June 02, 2016

In many contexts where Doctors Without Borders/Médecins Sans Frontières (MSF) works, key populations (also referred to as most-at-risk populations) such as sex workers and men who have sex with men have a higher risk of contracting HIV and a lower ability to access antiretroviral care due to stigma, discrimination, and their high mobility.

May 19, 2016

The O’Neill Report is the British Government’s response to tackling the emerging antibiotic resistance crisis. In order to overcome this global threat, all countries must play their part and take action to address the crisis, including funding research and development for new tools—new classes of antibiotics, but also diagnostics and vaccines—while ensuring sustainable and affordable access for those new tools. At the same time, steps need to be taken to conserve existing antibiotics for as long as possible.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

February 17, 2016

Whitney Ward, a Doctors Without Borders/Médecins Sans Frontières (MSF) field coordinator in Malawi, explains the need for increased humanitarian assistance for over 5,000 Mozambicans who fled to Malawi's Kapise village to escape violence.

What are living conditions like in Kapise?

I’ve worked in several camps and I haven’t seen such levels of overcrowding.

December 01, 2015

Lifesaving antiretroviral medicines (ARVs) are routinely not making their way to patients in sub-Saharan Africa, most often despite sufficient stocks already being present in countries.

Pages